autoimmunity Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting autoimmunity clinical trials across 22 countries. Studies span Not Applicable, Phase 1, Phase 4. Top locations include Milan, Milano, Italy, Bangalore, Karnataka, India, Baotou, Inner Mongolia, China. Updated daily from ClinicalTrials.gov.


autoimmunity Trials at a Glance

8 actively recruiting trials for autoimmunity are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Milan, Bangalore, and Baotou. Lead sponsors running autoimmunity studies include Scientific Institute San Raffaele, Laura ICONARU, and Göteborg University.

Browse autoimmunity trials by phase

Treatments under study

About autoimmunity Clinical Trials

Looking for clinical trials for autoimmunity? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new autoimmunity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about autoimmunity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

NIAID Centralized Sequencing Protocol

autoimmunityPrimary ImmunodeficiencyAtopy+1 more
National Institute of Allergy and Infectious Diseases (NIAID)20,000 enrolled2 locationsNCT03206099
Recruiting
Phase 4

Secukinumab Open Label Roll-over Extension Protocol

Autoimmunity, Inflammation
Novartis Pharmaceuticals1,000 enrolled167 locationsNCT04638647
Recruiting

Autoimmunity After Checkpoint Blockade

autoimmunityCancerOncology+1 more
Abramson Cancer Center at Penn Medicine600 enrolled1 locationNCT04119713
Recruiting
Phase 1

First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RB201 in Healthy Adult Subjects

autoimmunity
Rarefied Biosciences Australia PTY LTD88 enrolled1 locationACTRN12625000694415
Recruiting
Not Applicable

Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy

autoimmunity
Laura ICONARU500 enrolled3 locationsNCT06993727
Recruiting
Not Applicable

Gfree - For Improved Blood Sugar and Reduced Inflammation.

autoimmunityMetabolic DiseaseDiabetes+1 more
Göteborg University60 enrolled2 locationsNCT05894746
Recruiting

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)

autoimmunityCardiomyopathiesGenetic Predisposition+6 more
Scientific Institute San Raffaele20 enrolled1 locationNCT06591260
Recruiting

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

autoimmunityCardiomyopathiesGenetic Predisposition+6 more
Scientific Institute San Raffaele1,000 enrolled1 locationNCT04521790